-
Antibiotic Avelox Linked To Severe Liver Injury Side Effects, Again
Will The FDA Be The Last To Insist On Increased Warning; In Fall 2007 Bayer Updated Its Avalox Label In Europe (Posted by Tom Lamb at DrugInjuryWatch.com) On March 22, 2010 Health Canada issued a press…
-
March 2010: FDA Warns About Highest Dose Of Zocor Causing Myopathy And Rhabdomyolysis
Active Ingredient Simvastatin Is Found In Vytorin, With Zetia, And Simcor, With Niacin, Also (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________________________________________________________ UPDATE: FDA Drug Safety Communication: New restrictions, contraindications, and dose limitations for Zocor…
-
FDA And Novartis Announce A Label Change For Iron Chelating Drug Exjade In Mid-February 2010
Includes A New "Black Box" Warning About Renal Impairment, Liver Failure, And Gastrointestinal Hemorrhage (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-February 2010 the FDA and Novartis announced a change to the Prescribing Information…
-
Focus On Fosamax
________________________________________________________ Free Fosamax Case Evaluation The information you provide to us for this Free Case Evaluation will be treated as strictly confidential. You will get a reply from us no later than the next business…
-
Some Seroquel Documents From AstraZeneca Now Available At The Drug Industry Document Archive
These 241 "New" Documents Show How Drug Company Obscured Potential For Patient Weight Gain And Diabetes (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-February 2010 Kim Klausner, the Industry Documents Digital Libraries Manager for…
-
Recent Report About Ortho Evra Safety Seems To Contradict Earlier Findings From Same Group
Third Boston Collaborative Drug Surveillance Program Study Analysis Concerning Ortho Evra And Blood Clot Side Effect Risk Causes Confusion (Posted by Tom Lamb at DrugInjuryWatch.com)Let us start with this relatively recent medical journal article, "Postmarketing study of…
